Chronic Pain — 29 January 2013

By Mark Maginn, Columnist

Hydrocodonebtibu75200-300x224People living with pain sustained another jolt last week at the hands of a Food and Drug Administration advisory panel. The panel voted 19 to 10 to recommend that Vicodin and other hydrocodone products be reclassified from Schedule III controlled substances to  Schedule II drugs, thus making these much used and needed medicines for pain patients harder to obtain.

Read more at National Pain Report.


About Author

Mark Maginn, Columnist

Mark is a poet, writer and social justice activist. Mark suffers from chronic pain and was a longtime volunteer with the American Pain Foundation.

(0) Readers Comments

Comments are closed.